Autologous Peripheral Blood Mononuclear Cells as Treatment in Refractory Acute Respiratory Distress Syndrome
暂无分享,去创建一个
T. Luedde | O. Hermanson | P. Macchiarini | M. Wood | E. Alici | C. Roderburg | A. Teixeira | J. Nordin | S. El Andaloussi | O. Wiklander | P. Jungebluth | O. Winqvist | B. Anderstam | Sebastian Sjöqvist | Vanessa Lundin | M. Lim | Johannes C. Haag | Y. Gustafsson | N. Heldring | Joel Z. Nordin | B. Holzgraefe | Petra Jones | M. Chrobok | A. D. Duru | H. Kalzén | Antonio Beltrán Rodríguez | K. G. Roddewig | A. Duru
[1] N. Pimpinelli,et al. Induction of CD83+CD14+ Nondendritic Antigen-Presenting Cells by Exposure of Monocytes to IFN-α1 , 2008, The Journal of Immunology.
[2] M. Goumans,et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. , 2011, Stem cell research.
[3] L. Farkas,et al. Vascular Repair and Regeneration as a Therapeutic Target for Pulmonary Arterial Hypertension , 2013, Respiration.
[4] E. Rossmanith,et al. Monocytes, Peripheral Blood Mononuclear Cells, and THP-1 Cells Exhibit Different Cytokine Expression Patterns following Stimulation with Lipopolysaccharide , 2013, Mediators of inflammation.
[5] D. Weiss. Concise Review: Current Status of Stem Cells and Regenerative Medicine in Lung Biology and Diseases , 2014, Stem cells.
[6] Jae W. Lee,et al. Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 , 2007, The Journal of Immunology.
[7] C. Sølling. Organ-protective and immunomodulatory effects of erythropoietin--an update on recent clinical trials. , 2012, Basic & clinical pharmacology & toxicology.
[8] M. Rojas,et al. Mesenchymal Stem Cells: A Promising Therapy for the Acute Respiratory Distress Syndrome , 2013, Respiration.
[9] M. Dobbelstein,et al. MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia , 2010, Cell cycle.
[10] M. Rojas,et al. Infusion of freshly isolated autologous bone marrow derived mononuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model , 2013, Stem Cell Research & Therapy.
[11] M. Brines. The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors , 2010, Blood Purification.
[12] B. Thompson,et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. , 2015, The Lancet. Respiratory medicine.
[13] T. Luedde,et al. Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.
[14] Moustapha Hassan,et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.
[15] Kristen Jepsen,et al. Deconstructing repression: evolving models of co-repressor action , 2010, Nature Reviews Genetics.
[16] D. Golde. The stem cell. , 1991, Scientific American.
[17] Arthur S Slutsky,et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.
[18] P. Macchiarini,et al. Stem cell-based therapy and regenerative approaches to diseases of the respiratory system. , 2011, British medical bulletin.
[19] M. Blanco-Gelaz,et al. Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy. , 2013, Transplantation proceedings.
[20] R. Casaburi,et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. , 2013, Chest.
[21] Paolo Macchiarini,et al. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach , 2010, Journal of cellular and molecular medicine.
[22] M. Rojas,et al. Adult stem cells for chronic lung diseases , 2013, Respirology.
[23] Staffan Strömblad,et al. RETRACTED: Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study , 2011, The Lancet.
[24] Demosthenes Bouros,et al. Stem Cell Treatment for Chronic Lung Diseases , 2013, Respiration.
[25] J. Laffey,et al. Acute lung injury/acute respiratory distress syndrome-a therapeutic challenge , 2012 .
[26] M. Rojas,et al. The potential of cell-based therapy in lung diseases , 2013, Expert opinion on biological therapy.
[27] Allison N. Lau,et al. Stem cells and regenerative medicine in lung biology and diseases. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] S. Rakshit,et al. Granulocyte–macrophage colony‐stimulating factor drives monocytes to CD14low CD83+ DCSIGN– interleukin‐10‐producing myeloid cells with differential effects on T‐cell subsets , 2007, Immunology.
[29] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[30] M. Epple,et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease , 2014, Leukemia.
[31] D. Stewart,et al. Competing Interests: This work was , 2022 .
[32] K. Palmér,et al. Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure. , 2010, Minerva anestesiologica.
[33] Neil D. Theise,et al. Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.
[34] Peng-jun Zhang,et al. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects , 2012, Clinical chemistry and laboratory medicine.
[35] H. Perkins,et al. Concise review: Current status of the HLA system , 1979 .
[36] A. Cerami,et al. Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response , 2008, Journal of internal medicine.
[37] H. Schäfers,et al. Erythropoietin inhibits post-ischemic leukocyte adhesion but does not affect rejection in murine cardiac allografts. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[38] S. Janes,et al. Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy , 2013, Respiration.
[39] 室井 一男. What's going on 造血器腫瘍 1)Human mesenchymal stem cells modulate allogeneic immune cell responses. Aggarwal S, Pittenger MF. Blood. 2005;105:1815-22. PMID:15494428. 2)Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Le Blanc K, Rasmusson I, Sun , 2005 .
[40] K. Delucchi,et al. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome , 2014, Annals of Intensive Care.
[41] A. Medford,et al. Advances in Understanding of the Pathogenesis of Acute Respiratory Distress Syndrome , 2015, Respiration.
[42] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .
[43] Imre Mäger,et al. Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.